Currently, HIV diagnosis relies on serology. Yet in groups at high ris
k for HIV serology is not sufficient because of the window period betw
een infection and seroconversion. There is a growing body of reports o
n HIV-infected yet seronegative individuals. Some tests have been deve
loped to identify exposure to HIV by its effect on the cells of the im
mune system that would differentiate following exposure to the foreign
antigens. Detection, in vitro, of HIV-specific B and T cells in seron
egative, at risk individuals has been reported. In only some of these
individuals was an HIV infection confirmed by other methods. These new
assays to detect HIV immunity enable us to identify two new groups am
ong seronegative, at risk individuals; namely those with immunity to H
IV and a detectable HIV infection (silent carriers), and those with im
munity and no proof of infection. Both groups have been exposed to MV
yet are not being detected by serology. Both might hold information on
other forms of HIV immunity, possibly a protective one. Thus there co
uld be an important role for other immunological assays in early detec
tion of HIV exposure.